Drug Profile
Research programme: cytomegalovirus vaccine - Henderson Morley
Latest Information Update: 30 May 2011
Price :
$50
*
At a glance
- Originator Henderson Morley
- Class Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cytomegalovirus infections
Most Recent Events
- 31 Jan 2008 Preclinical trials in Cytomegalovirus infections prevention in United Kingdom (Parenteral)